Literature DB >> 21290351

[The IC3D classification of the corneal dystrophies].

J S Weiss1, H U Møller, W Lisch, S Kinoshita, A J Aldave, M W Belin, T Kivelä, M Busin, F L Munier, B Seitz, J Sutphin, C Bredrup, M J Mannis, C Rapuano, G Van Rij, E K Kim, G K Klintworth.   

Abstract

BACKGROUND: The recent availability of genetic analyses has demonstrated the shortcomings of the current phenotypic method of corneal dystrophy classification. Abnormalities in different genes can cause a single phenotype, whereas different defects in a single gene can cause different phenotypes. Some disorders termed corneal dystrophies do not appear to have a genetic basis.
PURPOSE: The purpose of this study was to develop a new classification system for corneal dystrophies, integrating up-to-date information on phenotypic description, pathologic examination, and genetic analysis.
METHODS: The International Committee for Classification of Corneal Dystrophies (IC3D) was created to devise a current and accurate nomenclature.
RESULTS: This anatomic classification continues to organize dystrophies according to the level chiefly affected. Each dystrophy has a template summarizing genetic, clinical, and pathologic information. A category number from 1 through 4 is assigned, reflecting the level of evidence supporting the existence of a given dystrophy. The most defined dystrophies belong to category 1 (a well-defined corneal dystrophy in which a gene has been mapped and identified and specific mutations are known) and the least defined belong to category 4 (a suspected dystrophy where the clinical and genetic evidence is not yet convincing). The nomenclature may be updated over time as new information regarding the dystrophies becomes available.
CONCLUSIONS: The IC3D Classification of Corneal Dystrophies is a new classification system that incorporates many aspects of the traditional definitions of corneal dystrophies with new genetic, clinical, and pathologic information. Standardized templates provide key information that includes a level of evidence for there being a corneal dystrophy. The system is user-friendly and upgradeable and can be retrieved on the website www.corneasociety.org/ic3d . © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 21290351     DOI: 10.1055/s-0029-1245895

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  8 in total

1.  [Bilateral disc-like corneal opacity before cataract extraction].

Authors:  J M Rohrbach; G Willmann; W Lisch
Journal:  Ophthalmologe       Date:  2011-11       Impact factor: 1.059

2.  [New international classification of corneal dystrophies (CD)].

Authors:  W Lisch; B Seitz
Journal:  Ophthalmologe       Date:  2011-09       Impact factor: 1.059

3.  A recognition survey of granular corneal dystrophy type 2 genetic detection in China.

Authors:  Xin-Rui Wang; Bi-Ting Zhou; Qing-Mei Zheng; Ya-Duan Wang; Qiu-Kai Huang; Xuan Song; He Wang; Nan-Wen Zhang; Yi-Hua Zhu; Xiao-Le Chen; Ju-Hua Yang
Journal:  Int J Ophthalmol       Date:  2020-12-18       Impact factor: 1.779

4.  [Salzmann's nodular degeneration. Mostly an epithelial corneal dystrophy].

Authors:  R Sundmacher
Journal:  Ophthalmologe       Date:  2012-04       Impact factor: 1.059

5.  [Discrete bilateral corneal deposits in a young woman].

Authors:  J M Rohrbach; B Sobolewska; K Helaiwa; W Lisch
Journal:  Ophthalmologe       Date:  2012-12       Impact factor: 1.059

6.  Identification of novel molecular markers through transcriptomic analysis in human fetal and adult corneal endothelial cells.

Authors:  Yinyin Chen; Kevin Huang; Martin N Nakatsu; Zhigang Xue; Sophie X Deng; Guoping Fan
Journal:  Hum Mol Genet       Date:  2012-12-20       Impact factor: 6.150

7.  Endothelial cell density in children with posterior polymorphous corneal dystrophy: a longitudinal case-control study.

Authors:  Simon Sheung Man Fung; Hamza Sami; Ali El Hamouly; Dishay Jiandani; Sara Williams; Kamiar Mireskandari; Asim Ali
Journal:  Eye (Lond)       Date:  2021-02-19       Impact factor: 3.775

8.  Towards personalised allele-specific CRISPR gene editing to treat autosomal dominant disorders.

Authors:  Kathleen A Christie; David G Courtney; Larry A DeDionisio; Connie Chao Shern; Shyamasree De Majumdar; Laura C Mairs; M Andrew Nesbit; C B Tara Moore
Journal:  Sci Rep       Date:  2017-11-23       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.